3.75 mg lyophilised powder for preparation of solution for I.M. and subcutaneous injection vial №1 + 1.5 mL solvent (5% Mannitol solution) ampoule №1 + single-use syringe №1 + needles №2
Concentration
Excipients
Manufacturing site GMP status
US FDA establishment registration (FEI; registration is not an FDA approval)
API manufacturing site GMP status
Additional GMP certification
Therapeutic Area
Country of manufacture
Manufacturing site country
Additional Information
No items found.
Prescription-only medicine. This information is intended for healthcare professionals and prospective business partners. It is not promotional material and is not intended for patients. For approved product information, consult the Georgian medicines register or contact us. To report a suspected side effect from a medicine supplied by Mermisi, please contact us.
.png)